Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation

References

• Aversa F, Tabilio A, Velardi A, et al. Treatment of high risk acute leukemia with T-depleted stem cells from related donors with one fully mismatched HLA haplotype. New Engl J Med 1998; 339: 1186–93
   PubMed Web of Science ®Google Scholar
• Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097–100
   PubMed Web of Science ®Google Scholar
• Kärre K, Ljunggren HG, Piontek G, Kiessling R. Selective rejection of H-2 deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986; 319: 675–8
   PubMed Web of Science ®Google Scholar
• Farag SS, Fehniger TA, Ruggeri L, et al. Natural killer cell receptors: new biology and insights into the graft versus leukemia effect. Blood 2002; 100: 1935–47
   PubMed Web of Science ®Google Scholar
• Velardi A, Ruggeri L, Moretta A, Moretta L. NK-cells: a lesson from mismatched haematopoietic transplantation. Trends Immunol 2002; 23: 438–44
   PubMed Web of Science ®Google Scholar
• Uhrberg M, Valiante NM, Shum BP, et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997; 7: 753–60
   PubMed Web of Science ®Google Scholar
• Ruggeri L, Capanni M, Mancusi A, et al. Impact of NK cell alloreactivity on mismatched haematopoietic transplantation: an update on donor selection criteria and on transplantation outcomes. Bone Marrow Transpl 2004; 33: S68[EF6]
   Web of Science ®Google Scholar
• Shilling H, Young N, Guethlein LA, et al. Genetic control of human NK cell repertoire. J Immunol 2002; 169: 239–47
   PubMed Web of Science ®Google Scholar
• Ruggeri L, Capanni M, Casucci M, et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 1999; 94: 333–9
   PubMed Web of Science ®Google Scholar
• Davies SM, Ruggeri L, DeFor T, et al. Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Blood 2002; 100: 3825–7
   PubMed Web of Science ®Google Scholar
• Giebel S, Locatelli F, Lamparelli T, et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 2003; 102: 814–19
   PubMed Web of Science ®Google Scholar
• Lowe EJ, Turner V, Handgretinger H, et al. T-cell alloreactivity dominates natural killer cell alloreactivity in minimally T-cell-depleted HLA-non-identical paediatric bone marrow transplantation. Br J Haematol 2003; 123: 323–6
   PubMed Web of Science ®Google Scholar
• Morishima Y, Yabe T, Inoko H, et al. Clinical significance of killer Ig-like receptor (KIR) on acute GvHD, rejection and leukemia relapse in patients transplanted non-T cell depleted marrow from unrelated donors; roles of inhibitory KIR epitope matching and activating KIR genotype [abstract]. Blood 2003; 102: 526a
   Web of Science ®Google Scholar
• Beelen DW, Ottinger H, Ferencik S, et al. KIR ligand disparities are associated with a decreased risk of relapse after allogeneic stem cell transplantation for myeloid leukaemia [abstract]. Bone Marrow Transplant 2004; 33: S17
   Web of Science ®Google Scholar
• Elmaagacli AH, Ottinger H, Koldehoff M, et al. Reduced risk of molecular and haematological relapse in patients with CML after KIR-mismatched haematopoietic stem cell transplantation [abstract]. Bone Marrow Transplant 2004; 33: S59
   Web of Science ®Google Scholar
• Bornhauser M, Schwerdtfeger R, Martin H, et al. Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors [letter]. Blood 2004; 103: 2860–1
   PubMed Web of Science ®Google Scholar
• Shilling HG, McQueen KL, Cheng NW, et al. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Blood 2003; 101: 3730–40
   PubMed Web of Science ®Google Scholar
• Pando MJ, Gardiner CM, Gleimer M, et al. The protein made from a common allele of KIR3DL1 (3DL*004) is poorly expressed at cell surfaces due to substitution at position 86 in Ig domain 0 and 182 in Ig domain 1. J Immunol 2003; 171: 6640–7
   PubMed Web of Science ®Google Scholar
• Krenger W, Rossi S, Piali L, Holländer GA. Thymic atrophy in murine acute graft-versus-host disease is effected by impaired cell cycle progression of host pro-T and pre-T cells. Blood 2000; 96: 347–54
   PubMed Web of Science ®Google Scholar
• Burchielli E, Ruggeri L, Hafen K, et al. NK cell conditioning to T cell-replete mismatched bone marrow transplantation protects thymic structure and function [abstract]. Bone Marrow Transpl 2004; 33: S56
   Google Scholar
• Ruggeri L, Perruccio K, Montagnoli C, et al. NK cell conditioning to T cell-replete mismatched bmt confers immediate responsiveness to infectious challenges [abstract]. Bone Marrow Transpl 2004; 33: S18
   Web of Science ®Google Scholar